Clinical trial
Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized…
NCT00142272 · International Centre for Diarrhoeal Disease Research, Bangladesh, Other · Completed
Key facts
| NCT number | NCT00142272 |
|---|---|
| Title | Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial |
| Official title | Randomised, Open, Parallel Group Clinical Trial to Compare the Efficacy and Safety of a Single Dose of Ciprofloxacin Oral Suspension 20 mg/kg With a 3-day Course of Erythromycin Oral Suspension Administered in a Dose of 12.5 mg/kg Every 6 Hours (12 Doses) in the Treatment of Children,With Clinically… |
| Lead sponsor | International Centre for Diarrhoeal Disease Research, Bangladesh, Other |
| Collaborators | Bayer Industry NEMC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cholera |
| Intervention type | Drug |
| Interventions | Ciprofloxacin |
| Enrollment | 180 |
| Start date | May 1, 2001 |
| Completion | Jul 1, 2002 |
| First posted | Sep 2, 2005 |
| Last update posted | Feb 11, 2022 |
| Countries | Bangladesh |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: